The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Individualized Prediction of Colon Cancer Recurrence Using a Nomogram
Abstract
Purpose: Estimates of recurrence after curative colon cancer surgery are integral to patient care, forming the basis of cancer staging and treatment planning. The categoric staging system of the American Joint Committee on Cancer (AJCC) is commonly used to convey risk by grouping patients based on anatomic elements. Although easy to implement, there remains significant heterogeneity within each stage grouping. In the era of multimodality treatment, a more refined tool is needed to predict recurrence. Methods: An institutional database of 1,320 patients with nonmetastatic colon cancer was used to develop a nomogram to estimate recurrence after curative surgery. Prognostic factors were assessed with multivariable analysis using Cox regression, whereas nonlinear continuous variables were modeled with cubic splines. The model was internally validated with bootstrapping, and performance was assessed by concordance index and a calibration curve. Results: The colon cancer recurrence nomogram predicted relapse with a concordance index of 0.77, improving on the stratification provided by either the AJCC fifth or sixth staging scheme. Factors in the model included patient age, tumor location, preoperative carcinoembryonic antigen, T stage, numbers of positive and negative lymph nodes, lymphovascular invasion, perineural invasion, and use of postoperative chemotherapy. Conclusion: Using common clinicopathologic factors, the recurrence nomogram is better able to account for tumor and patient heterogeneity, thereby providing a more individualized outcome prognostication than that afforded by the AJCC categoric system. By identifying both the high- and low-risk patients within any particular stage, the nomogram is expected to aid in treatment planning and future trial design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
O'Connell, J. B., Maggard, M. A., & Ko, C. Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh275 · Cited by 1,599
The classification of cancer of the rectum
Dukes, C. E. (1932) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700350303 · Cited by 1,505
Benson, A. B., Schrag, D., Somerfield, M. R., Cohen, A. M., Figueredo, A. T., Flynn, P. J., Krzyzanowska, M. K., Maroun, J., McAllister, P., Van Cutsem, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.063 · Cited by 1,430
Self-citationA Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
Kattan, M. W., Eastham, J. A., Stapleton, A. M. F., Wheeler, T. M., & Scardino, P. T. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.10.766 · Cited by 1,242
Self-citation
Cited by
Nomograms in oncology: more than meets the eye
Balachandran, V. P., Gonen, M., Smith, J. J., & DeMatteo, R. P. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71116-7 · Cited by 3,292
Self-citationEarly colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Labianca, R., Nordlinger, B., Beretta, G. D., Mosconi, S., Mandalà, M., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt354 · Cited by 1,404
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Argilés, G., Tabernero, J., Labianca, R., Hochhauser, D., Salazar, R., Iveson, T., Laurent-Puig, P., Quirke, P., Yoshino, T., Taieb, J., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.022 · Cited by 1,375
Valentini, V., van Stiphout, R. G. P. M., Lammering, G., Gambacorta, M. A., Barba, M. C., Bebenek, M., Bonnetain, F., Bosset, J.-F., Bujko, K., Cionini, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1595 · Cited by 563
Jorissen, R. N., Gibbs, P., Christie, M., Prakash, S., Lipton, L., Desai, J., Kerr, D., Aaltonen, L. A., Arango, D., Kruhøffer, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1431 · Cited by 437
Labianca, R., Beretta, G. D., Kildani, B., Milesi, L., Merlin, F., Mosconi, S., Pessi, M. A., Prochilo, T., Quadri, A., Gatta, G., et al. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.01.010 · Cited by 409
Compton, C. C., Byrd, D. R., Garcia-Aguilar, J., Kurtzman, S. H., Olawaiye, A., & Washington, M. K. (2012) · AJCC Cancer Staging Atlas · doi:10.1007/978-1-4614-2080-4_14 · Cited by 395
Labianca, R., Nordlinger, B., Beretta, G. D., Brouquet, A., & Cervantes, A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq168 · Cited by 340
Rudloff, U., Jacks, L. M., Goldberg, J. I., Wynveen, C. A., Brogi, E., Patil, S., & Van Zee, K. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8847 · Cited by 318
Kononen, D. W., Flannagan, C. A. C., & Wang, S. C. (2011) · Accident Analysis & Prevention · doi:10.1016/j.aap.2010.07.018 · Cited by 263
Perineural Invasion Is a Strong Prognostic Factor in Colorectal Cancer: A Systematic Review
Knijn, N., Mogk, S. C., Teerenstra, S., Simmer, F., & Nagtegaal, I. D. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000518 · Cited by 253
Interpretable survival prediction for colorectal cancer using deep learning
Wulczyn, E., Steiner, D. F., Moran, M., Plass, M., Reihs, R., Tan, F., Flament-Auvigne, I., Brown, T., Regitnig, P., Chen, P.-H. C., et al. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00427-2 · Cited by 231
“While additional data, such as clinical variables, histopathologic parameters, and molecular features can provide important information 2,3 , there remains a need for more precise patient risk strati fi cation to improve patient management and disease outcomes.”
BackgroundFrom past to future: Bibliometric analysis of global research productivity on nomogram (2000–2021)
Wang, X., Lu, J., Song, Z., Zhou, Y., Liu, T., & Zhang, D. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.997713 · Cited by 140
“In 2008, Weiser incorporated clinicopathological variables to establish a nomograph that could be used to predict recurrence in patients with colorectal cancer after surgery (18).”
MethodThe Impact of Neural Invasion Severity in Gastrointestinal Malignancies: A Clinicopathological Study
Liebl, F., Demir, I. E., Mayer, K., Schuster, T., D'Haese, J. G., Becker, K., Langer, R., Bergmann, F., Wang, K., Rosenberg, R., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000968 · Cited by 131
Metadata
- Authors
- Weiser, M. R., Landmann, R. G., Kattan, M. W., Gonen, M., Shia, J., Chou, J., Paty, P. B., Guillem, J. G., Temple, L. K., Schrag, D., Saltz, L. B., & Wong, W. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-01-20
- Volume
- 26
- Issue
- 3
- Pages
- 380-385
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2119107631
- Cited by
- 303
- References
- 17
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.